There are different ways to check that the target gene has been modified, being a successful CRISPR experiment.
An experiment is considered successful when the target DNA has been cut only at the point for which it was designed, introducing a mutation that produces a change in the expression of the target gene.
Learn more in this article on Abyntek Biopharma blog:
Do you want to know more about CRISPR/Cas technology?
On 19 October we have organised a seminar to explain this technology by Dr. Nerea Arias Jayo, PhD, Scientific Director of ABYNTEK BIOPHARMA. If you want to attend, you can see all the information here.